THE INTERSECTION OF BRAIN SCIENCE & HUMAN POTENTIALPartner with us
neurofeedback.com
The newsletter
← Research & Evidence
Positive with limitationsMulticenter retrospective longitudinal matched case-control analysis with nested cross-validation

Predicting levetiracetam neuropsychiatric adverse effects using graph-theoretical electroencephalographic network metrics in drug-naive focal epilepsy: A multicenter longitudinal study.

Pretreatment EEG network features showed a moderate signal for identifying people who later had important levetiracetam side effects. The model needs prospective external validation before clinical use.

Sferruzzi M, Ricci L, Matarrese MAG, Izzi F, Placidi F, Sancetta BM, Cerulli Irelli E, Pulitano P, Di Lazzaro V, Tombini M, Assenza G.
Epilepsia · Publication date: 2026-09-22
Added to site: 2026-09-24
DOI: 10.1002/epi.70486

Electronic publication date verified in Europe PMC; first indexed 2026-09-23. This source date is separate from the site's addition date.

Modalities
QEEG, EEG
Clinical focus
Epilepsy, Medication tolerability, Predictive biomarkers
Population
Drug-naive people with focal epilepsy treated at three Italian centers
Sample
62 people selected from a 134-person levetiracetam monotherapy cohort: all 31 with clinically significant neuropsychiatric adverse effects and 31 age- and sex-matched controls
Intervention / method
Resting EEG within 30 days before levetiracetam, with theta-band connectivity graph metrics entered into an elastic-net classifier
Comparator
Patients who developed clinically significant adverse effects within one month versus matched patients without those effects

Clinician summary

Theta-band clustering coefficient, path length and node strength were higher in the adverse-effect group. Nested cross-validation produced 0.71 accuracy and 0.71 AUC, with a wide AUC confidence interval of 0.57 to 0.83; spectral power did not differ.

How to interpret the findings

Retrospective matched subset from a modest cohort, internal validation only and imprecise discrimination. Case-control sampling does not provide real-world positive predictive value, and no prospective decision threshold or external clinical utility was established.

Equipment and disclosures

EEG acquisition systems and montage details were not available in the checked abstract.

Funding and competing-interest details were not available in the checked indexed record.

Related evidence

Compare findings from the same clinical area, including mixed results.

Abstract checked · Checked 2026-09-24

Summary prepared with AI assistance. Source verification does not imply an independent replication or a clinician's endorsement. Read our review method.